[1] |
李敬云. HIV耐药的现状趋势与应对[J]. 中国艾滋病性病, 2018, 179(6): 635-638.
|
[2] |
Hao MQ, Wang J, He SF, et al.Identification of a novel HIV-1 second-generation recombinant form (CRF01_AE/07_BC) in men who have sex with men in Beijing, China[J]. AIDS Res Hum Retroviruses, 2019, 35(5): 500-504.
|
[3] |
Chang WH, Zhang MY, Ren Q, et al.HIV-1 genetic diversity and recombinant forms among men who have sex with men at a sentinel surveillance site in Xi'an City, China[J]. Infect Genet Evol, 2020, 81: 104257.
|
[4] |
WHO. HIV drug resistance survey: tool for data entry[R]. Geneva: WHO, 2017.
|
[5] |
吴守丽, 刘峰, 颜苹苹, 等. HIV-1耐药突变的研究进展[J]. 中国人兽共患病学报, 2018, 34(1): 44-53.
|
[6] |
Wang ZY, Zhang M, Zhang RF, et al.Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China[J]. BMC Infect Dis, 2019, 19(1): 313-317.
|
[7] |
吴昊, 张亚丽, 高凯, 等. 广州市2015年男男性行为者HIV-1感染者亚型和耐药研究[J]. 中国艾滋病性病, 2018, 24(6): 569-572.
|
[8] |
吕星, 郑成丽, 刘少础, 等. 2011—2013年深圳市新报告男男性行为传播的HIV-1感染者原发性耐药及相关因素[J]. 中国艾滋病性病, 2019, 12(25):1242-1245.
|
[9] |
Lu XL, Zhao HR, Zhang YQ, et al.HIV-1 drug resistant mutation and related risk factors among HIV-1 positive individuals experiencing treatment failure in Hebei Province, China[J]. AIDS Res Ther, 2017, 14(1):4-8.
|
[10] |
陈瑶,吴英松.HIV-1耐药基因检测的研究进展[J]. 分子诊断与治疗杂志, 2017, 48(2):142-146.
|
[11] |
Guo JL, Yan Y, Zhang JF, et al.Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China[J]. Oncotarget, 2017, 8(11): 18271-18276.
|
[12] |
Lu XL, Kang XJ, Liu YJ, et al.HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China[J]. PLoS One, 2017, 12(2): e0171481.
|